Methodist Research Institute Inc

Nonprofit profile at a glance

EIN
352023710
IRS 990 coverage
2011–2017
Forms available
Form 990 2017
Location
Indianapolis, IN, USA
Phone
3179634842
Rating
59
Verdict
MIXED
Rating confidence
Moderate
Sector
Protestant
Affiliation
Christianity

Reported finances

Revenue
$2,707,760
Expenses
$2,707,760
Assets
$0
Liabilities
$0

Source: IRS Form 990. Selected filing: tax year 2017. Amounts in USD.

Leadership & pay

9 people listed

Executive titles in this filing

  • CARY N MARIASH MD (DIRECTOR/MEDICAL DIRECTOR/CEO)

Highest reported compensation

  • JAMES E LINGEMAN MD (CHAIRMAN): $759,121 total reported compensation
  • CHRIS C NAUM MD (DIRECTOR): $631,470 total reported compensation
  • ARTHUR C COFFEY MD (DIRECTOR): $544,990 total reported compensation

Source: IRS Form 990. Selected filing: tax year 2017. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Engage primarily in the continuous active conduct of medical research and in general to engage in, promote and support the advancement of medical and surgical science.

What it reported doing in 2017

Methodist Research Institute, Inc. ("Methodist Research Institute") plays an integral role in Indiana University Health, Inc.s ("IU Healths") mission of improving the health of its patients and community by supporting innovative research in a number of important areas. The Clinical Research Group, in addition to providing clinical research support to the investigators at IU Health Methodist Hospital and embracing the initiative forged among IU Health, the Indiana University School of Medicine, and the Clinical and Translational Sciences Institute, is also expanding its services to other hospitals beyond IU Health Methodist Hospital. The clinical research nurses of Methodist Research Institute also provide study management from the early planning stages through subject enrollment, the procurement of specimens, and the collection and documentation of data at IU Health North Hospital and IU Health Saxony Hospital. The Biorepository at Methodist Research Institute, under IRB approval, collects human biological materials (blood, bone, tissue, urine) vital for medical research to provide the best way to study a variety of diseases and their potential treatments. The Methodist Research Institute Biorepository staff has streamlined the process of obtaining research samples from the operating room and preserving the samples in a crucial time-sensitive manner. Research is further supported through the medical research laboratory, where the groundbreaking work of doctors and investigators takes place, the specialized skill set of our data services providers who validate research and maintain data registries for clinical trials, our certified medical illustrator who explains concepts through images, and the grant writer and editor who helps investigators successfully complete grant submissions. The support of these areas, vital to research as a whole, sustain the mission of the Institute and have been expanded to meet the needs of researchers both on the IU Health Methodist Hospital campus and within other areas of the IU Health system.

Operating model

Revenue model
Mixed. Its operating money came from several sources; no one source provided a clear majority.
Distribution model
Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.

The verdict

MIXED - A large share of available resources goes toward mission work. A relatively small share of voting board members are independent and few specific pay-setting methods are documented in the filing; unanswered boxes are not proof of absence.

Rating breakdown

  • Financial Efficiency: 88
  • Transparency & Controls: 51
  • Accountability: 36
  • Sustainability: 19
  • Growth: 0

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 99.1%; rating input score 99
  • Program expense ratio: 99.1%; rating input score 99
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 90%; rating input score 90; 3rd percentile among comparable filings
  • Pay-setting controls: 0 of 6 controls in place; rating input score 0
    • Compensation committee: Missing
    • Independent consultant: Missing
    • Other Form 990s reviewed: Missing
    • Written employment contract: Missing
    • Compensation survey or study: Missing
    • Board or committee approval: Missing
  • Foreign activity oversight: Limited
  • Grant itemization coverage: Limited
  • Major donor itemization: No; rating input score 0
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 14.3%; rating input score 14; 5th percentile among comparable filings
  • Governance controls: 6 of 9 controls in place; rating input score 67
    • Conflict-of-interest policy: Pass
    • Whistleblower policy: Pass
    • Document-retention policy: Pass
    • CEO compensation review process: Fail
    • Other executive compensation review process: Fail
    • Form 990 shared with the board: Fail
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Pass
    • Independent financial-statement audit: Pass

Sustainability

  • Operating margin: 0%; rating input score 33; 33rd percentile among comparable filings
  • Total-asset coverage ratio: 0; rating input score 0; 0th percentile among comparable filings
  • Liabilities to assets ratio: Limited
  • Officer compensation ratio: 7.4%; rating input score 33; 33rd percentile among comparable filings

Growth

  • Program expense growth: -5.7% per year; rating input score 0; 9th percentile among comparable filings
  • Revenue growth: -9.4% per year; rating input score 0; 4th percentile among comparable filings
  • Asset growth: Limited

Details

  • Where the money goes: 99.1% of revenue deployed · 99.1% of spending went to programs
  • Governance: 1 of 7 board members independent · 6 of 9 filing controls reported
  • Programs: 1 filed program accomplishment · $2.7M in reported program spending
  • Leadership: top reported pay $759K · 9 people listed · 0 of 6 pay-setting controls reported
  • Consistency: 18 of 19 current checks pass · 1 finding to review
  • Schedules: 6 filed schedules · includes major donors and executive pay
  • Filing history: 7 filing years from 2011 to 2017
  • Contacts: How to reach this organization
  • Related organizations: 84 filed related-organization links
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • High — Accountability: Independent voting board scored 14/100.
  • High — Transparency & Controls: Pay-setting controls scored 0/100.
  • High — Transparency & Controls: Major donor itemization scored 0/100.
  • Review — Accountability: Governance controls: 3 of 9 not reported.
  • High — Growth: Program expense growth scored 0/100.
  • High — Growth: Revenue growth scored 0/100.
  • Moderate — Sustainability: Operating margin scored 33/100.
  • High — Sustainability: Total-asset coverage ratio scored 0/100.
  • Review — Transparency & Controls: Schedule R controlled transactions itemized did not reconcile in the filed values.
  • Moderate — Sustainability: Officer compensation ratio scored 33/100.